These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24083550)

  • 41. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis.
    Li M; Zhao Y; Zhao E; Wang K; Lu W; Yuan L
    Dis Markers; 2018; 2018():3947626. PubMed ID: 30581498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between polymorphisms in ERCC2 gene and oral cancer risk: evidence from a meta-analysis.
    Zhang E; Cui Z; Xu Z; Duan W; Huang S; Tan X; Yin Z; Sun C; Lu L
    BMC Cancer; 2013 Dec; 13():594. PubMed ID: 24330540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
    Chen Y; Yu X; Li T; Yan H; Mo Z
    Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERCC2 Lys751Gln polymorphism is associated with lung cancer among Caucasians.
    Zhang J; Gu SY; Zhang P; Jia Z; Chang JH
    Eur J Cancer; 2010 Sep; 46(13):2479-84. PubMed ID: 20627704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between the pre-mir-218 polymorphism and cancer risk in the Chinese population: a meta-analysis.
    Gao Y; Liu Y; Liu GL; Ran LK; Zeng F; Wu JY; Song FZ
    Asian Pac J Cancer Prev; 2014; 15(6):2517-22. PubMed ID: 24761857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancer.
    Zhang H; Zhang Y; Zhao X; Ma X; Yan W; Wang W; Zhao Z; Yang Q; Sun X; Luan H; Gao X; Zhang S
    Oncotarget; 2017 Jul; 8(29):46969-46980. PubMed ID: 28415619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Studies of ERCC2 rs13181 Polymorphism with Pancreatic Cancer Susceptibility.
    Shao T; Kou J
    Crit Rev Eukaryot Gene Expr; 2021; 31(2):17-23. PubMed ID: 34347976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D receptor BsmІ polymorphism and ovarian cancer risk: a meta-analysis.
    Qin X; Lu Y; Qin A; Chen Z; Peng Q; Deng Y; Xie L; Wang J; Li R; Zeng J; Li S; Zhao J
    Int J Gynecol Cancer; 2013 Sep; 23(7):1178-83. PubMed ID: 23873178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct effects of rs895819 on risk of different cancers: an update meta-analysis.
    Chen M; Fang W; Wu X; Bian S; Chen G; Lu L; Weng Y
    Oncotarget; 2017 Sep; 8(43):75336-75349. PubMed ID: 29088869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between ERCC2 rs13181 polymorphism and ovarian cancer risk: an updated meta-analysis with 4024 subjects.
    Li J; Pan L; Qin X; Chu H; Mu H; Wan G
    Arch Gynecol Obstet; 2017 Sep; 296(3):551-558. PubMed ID: 28676967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MSH3 rs26279 polymorphism increases cancer risk: a meta-analysis.
    Miao HK; Chen LP; Cai DP; Kong WJ; Xiao L; Lin J
    Int J Clin Exp Pathol; 2015; 8(9):11060-7. PubMed ID: 26617824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta-analysis of correlation between the CYP1A2 -3860 G > A polymorphism and lung cancer risk.
    Ren J; He BZ; Zhang TS; Lu SP; Yan T
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
    Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
    Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between Val66Met polymorphisms in brain-derived neurotrophic factor gene and asthma risk: a meta-analysis.
    Xie X; Zhu Y; Zhang J; Zhai C; Feng W; Pan Y; Liu L; Su X; Yang L; Li M
    Inflamm Res; 2015 Nov; 64(11):875-83. PubMed ID: 26289094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between ERCC2 polymorphisms and glioma risk: a meta-analysis.
    Huang LM; Shi X; Yan DF; Zheng M; Deng YJ; Zeng WC; Liu C; Lin XD
    Asian Pac J Cancer Prev; 2014; 15(11):4417-22. PubMed ID: 24969862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies.
    Zhao Y; Liang J; Qi JG; Yang N; Wu G; Lin YL; Cao JY; Wang Q; Wang QC
    Genet Mol Res; 2015 Jul; 14(3):7426-35. PubMed ID: 26214421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. XPD Asp312Asn polymorphism is a risk factor for prostate cancer.
    Liao SG; Liu L; Wang Y; Zhang YY; Wang YJ
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1689-95. PubMed ID: 22644997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic Polymorphism of DNA Methyltransferase 3A rs1550117 A>G and Risk of Cancer: A Meta-analysis.
    Zhang W; Xu Y; Ma G; Qi W; Gu H; Jiang P
    J Invest Surg; 2015; 28(6):346-53. PubMed ID: 26203494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.